The Importance of Curiosity in Expanding Cancer Immunology

Video

Jill O'Donnell-Tormey, PhD, chief executive officer, director of scientific affairs, Cancer Research Institute, discusses the importance of curiosity in expanding the role of immunology in the treatment of cancer.

Jill O’Donnell-Tormey, PhD, chief executive officer, director of scientific affairs, Cancer Research Institute, discusses the importance of curiosity in expanding the role of immunology in the treatment of patients with cancer.

It may be best from a scientific perspective to just ask great questions, have a curious mind, and follow new paths, O’Donnell-Tormey says. It is also important for researchers to not focus on what direction their work is going in, because science doesn’t necessarily work that way. James P. Allison, PhD, who was awarded a 2018 Nobel Prize in Physiology or Medicine along with Tasuku Honjo, MD, PhD, said in his acceptance speech that if he was trying to find a cure for cancer, he probably would not have discovered CTLA-4 as an immune checkpoint.

Researchers also need to understand that science takes time, persistence, and the ability to learn from failure. The field of immunotherapy is at a point now where oncologists can look at patient samples and figure out why immune resistance occurs. The lab is not the only place where research can be conducted, she concluded.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS